Veranstaltungen

Euronext - The journey of Life Science funding: IPOs and financial markets

With Oliver Schacht, PhD, CEO of Curetis N.V. as main guest Speaker. This presentation will go over the different aspects of the financial journey of biotechnology companies when going through an IPO process.

Date and place:
Thursday November 23rd, 2017
from 11:00 to 13:00
IZB
Room Kubus 1+2
Am Klopferspitz 19 + 19a
82152 Planegg / Martinsried
Germany

with Oliver Schacht, PhD, CEO of Curetis N.V. as main guest speaker

This presentation will go over the different aspects of the financial journey of biotechnology companies when going through an IPO process. Oliver Schacht, PhD, CEO of Curetis N.V., has extensive experience in developing and implementing commercial strategies and financing measures (including IPOs), as well as in finance, M&A transactions and alliance negotiations. He has been the CEO of Curetis N.V. since 2011, was a co-founder and CFO of Epigenomics AG in Berlin and CEO of the US subsidiary Epigenomics Inc. (Seattle, USA). 

Introduction by: Sebastian Grabert, Director - Representative for Germany,  Euronext  and Horst Domdey, CEO BioM, Martinsried

Followed by a Q&A session and a brunch reception.

The event is free but please register by sending an email to: AErdmann@remove-this.euronext.com

www.euronext.com